3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3 Ubunyulu ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

Inkcazelo emfutshane:

Igama leKhemikhali: 3,6-Difluoropyrazine-2-Carbonitrile

CAS: 356783-28-3

Imbonakalo: Mthubi oMthubi ukuya kumgubo oMhlophe

Ubunyulu: ≥99.0% (HPLC)

Umbindi weFavipiravir (CAS 259793-96-9) kunyango lweNtsholongwane yoMkhuhlane kunye ne-COVID-19

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo ngezoRhwebo lweFavipiravir kunye nabaPhakathi abaNxulumeneyo:
IFavipiravir CAS 259793-96-9
I-2-Aminopropanediamide CAS 62009-47-6
I-Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
I-3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Iipropati zeMichiza:

Igama leMchiza	3,6-Difluoropyrazine-2-Carbonitrile
Inombolo yeCAS	356783-28-3
Inombolo yeCAT	RF-PI227
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C5HF2N3
Ubunzima beMolekyuli	141.08
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Mthubi oMthubi ukuya kumgubo oMhlophe
Ubunyulu	≥99.0%
Ilahleko ekomisweni	≤1.0%
Intsalela ekutshisweni	≤0.50%
Ukungacoceki Okukodwa	≤0.50%
Ukungcola ngokupheleleyo	≤1.0%
Iintsimbi ezinzima	≤20ppm
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Umbindi weFavipiravir (CAS: 259793-96-9)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-3,6-Difluoropyrazine-2-Carbonitrile (CAS: 356783-28-3) iphakathi kweFavipiravir (CAS: 259793-96-9).I-Favipiravir yavunywa ukuba ithengiswe eJapan ngo-Matshi 2014 kwaye isetyenziselwa unyango lwe-antiviral ye-influenza A kunye ne-B. Ukongeza kwintsholongwane yomkhuhlane, iyeza libonise umsebenzi omhle we-antiviral kwiindidi ze-RNA, ezifana ne-Ebola virus, intsholongwane yesanti, Intsholongwane yeBunia, intsholongwane yomgada, njl njl. Inyumoniya entsha ye-coronavirus iyathintelwa luphando lwamva nje.